Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

NCT04331769 is registered in ClinicalTrials.gov with Ancora Heart, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04331769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Lead sponsor
Ancora Heart, Inc.
Phase
Not applicable
Overall status
Suspended
Start date
December 21, 2020
Completion date
December 21, 2030
Enrollment
400 (estimated)
Sites
122

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy, heart failure with reduced ejection fraction (hfref)